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Abstract
Fluorescent fusion proteins are widely used to study protein localization and interaction dynamics in living cells. However,
to fully characterize proteins and to understand their function it is crucial to determine biochemical characteristics such as
enzymatic activity and binding specificity. Here we demonstrate an easy, reliable and versatile medium/high-throughput
method to study biochemical and functional characteristics of fluorescent fusion proteins. Using a new system based on 96-
well micro plates comprising an immobilized GFP-binding protein (GFP-mulitTrap), we performed fast and efficient one-step
purification of different GFP- and YFP-fusion proteins from crude cell lysate. After immobilization we determined highly
reproducible binding ratios of cellular expressed GFP-fusion proteins to histone-tail peptides, DNA or selected RFP-fusion
proteins. In particular, we found Cbx1 preferentially binding to di-and trimethylated H3K9 that is abolished by
phosphorylation of the adjacent serine. DNA binding assays showed, that the MBD domain of MeCP2 discriminates between
fully methylated over unmethylated DNA and protein-protein interactions studies demonstrate, that the PBD domain of
Dnmt1 is essential for binding to PCNA. Moreover, using an ELISA-based approach, we detected endogenous PCNA and
histone H3 bound at GFP-fusions. In addition, we quantified the level of H3K4me2 on nucleosomes containing different
histone variants. In summary, we present an innovative medium/high-throughput approach to analyse binding specificities
of fluroescently labeled fusion proteins and to detect endogenous interacting factors in a fast and reliable manner in vitro.
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Introduction
Over the past decade a variety of proteomic approaches have
been used to identify cellular components in order to understand
the mechanism and inner workings of cells [1]. For example, mass
spectrometry-based proteomics uncovered the proteome of many
different organisms as well as cell-type specific differences in
protein expression. However, to understand and characterize the
function of single proteins, as well as the interplay between
different factors, it is essential to gain further insights into their
abundance, localization, dynamic interactions and substrate
specificities.
Fluorescent proteins like the green fluorescent proteins (GFP)
[2] and spectral variants have become popular tools to study the
localization and dynamic interactions of proteins in vivo. Despite,
the availability of a variety of commercial mono- and polyclonal
antibodies against GFP and other fluorescent proteins [3,4] (e.g.
Abcam, UK; Sigma, USA; Roche, Germany, ChromoTek,
Germany), proteins are mostly fused to a small epitope tag such
as FLAG or c-Myc to analyze biochemical characteristics like
enzymatic activities and/or binding specificities. Thus, integration
of such in vitro data with in vivo data obtained with fluorescently
labeled proteins has, in part, been impeded by the simple fact that
different protein tags are used for different applications. The gold
standard to examine binding affinities is surface plasmon
resonance (SPR) [5]. One drawback of this method is the need
of large amount of proteins. Such proteins have to be expressed
and purified from bacterial systems (e.g. E.coli) or lower eukaryotes
such as yeast (e.g. S. cerevisiae). Thus, the recombinant proteins lack
essential post-translational modifications or are not folded properly
possibly leading to different binding properties and inaccurate
results. In addition with SPR measurements one can only
determine the binding affinity to one substrate. This does not
reflect the in vivo situation where most proteins have the choice
between many different binding substrates in parallel.
Protein microarrays are an alternative to study protein-protein
interactions in high-throughput manner [6]. Once more the
drawback of this in vitro method is the laborative and time-
consuming preparation of recombinant proteins or protein
domains. Therefore protein microarrays are limited to domains
that can be produced as soluble, well-folded proteins [6].
Recently, specific GFP binding proteins based on single domain
antibodies derived from Lama alpaca have been described [7]
(GFP-Trap ChromoTek, Germany). The GFP-Trap exclusively
binds to wtGFP, eGFP and GFPS65T as well as to YFP and eYFP.
Coupling to matrices including agarose beads or magnetic
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particles the GFP-Trap allows for one-step purification of GFP-
fusion proteins. Previous studies made use of the GFP-Trap to
perform a broad range of different methods including mass
spectrometry analysis [8], DNA binding, DNA methyltransferase
activity assays [9], as-well-as histone-tail peptide binding assays
[10]. One mayor disadvantage of the GFP-Trap is, that batch
purification of GFP-fusions is very laborious and time-consuming
and one cannot test different GFP-fusion and/or assay conditions
in parallel. Here, we present an innovative and versatile high-
throughput method to quantitatively measure binding specificities
and to detect endogenous interacting factors in a fast and reliable
manner in vitro: 96-well micro plates coated with immobilized
GFP-Trap (GFP-multiTrap). To demonstrate the general suitabil-
ity of our assays, we choose already known binding partners and
compared our results with previous publications. Using this
method, we could confirm that Cbx1 preferentially binds to di-
and trimethylated histone H3 lysine 9 and that this binding is
abolished by phosphorylation of the adjacent serine 10 [11–13]. In
addition, we determined a 4-fold preference of the MBD domain
of MeCP2 for fully over unmethylated DNA in accordance to [14–
16]. Furthermore, we performed protein-protein interaction assays
and found that the Dnmt1 binds to PCNA in a PBD domain-
dependent manner consistent to [17,18]. In contrast, LigaseIII
binds Xrcc1 but does not interact with PCNA [19,20]. Using an
ELISA-based assay, we were able to detect endogenous PCNA
bound to immunoprecipiated Dnmt1, Fen1 and PCNA itself. In
accordance with our protein-protein interaction data, Dnmt1
lacking the PBD domain (Dnmt1DPBD) could not co-immuno-
precipate with PCNA. Consistent with our histone-tail peptide
binding data, we could detect endogenous histone H3 bound to
Cbx1. Finally, we quantified specific histone modifcations on
nucleosomes comprising different histone variants. All of these
data clearly demonstrate the versatility and easy handling of this
high-troughput approach and its immense benefit to many
researchers.
Results
One-step Purification of GFP-fusion Proteins
In a first step, we tested the efficiency of the GFP-multiTrap to
purify GFP-fusion proteins from cellular extracts. First, we
examined the pull-down efficiency of a GFP-tagged protein and
chose GFP-Cbx1 as a model protein. Cbx1 is a chromodomain-
containing protein related to the Drosophila HP1b, a well-studied
heterochromatin-associated protein [11]. We used cell extracts
from HEK293T cells transiently expressing GFP-Cbx1 or GFP,
purified the GFP-fusions using the GFP-multiTrap, eluted the
bound fractions, separated them by SDS-PAGE and visualized the
bound proteins by coomassie staining. The bound fractions
displayed mainly GFP as well as GFP-Cbx1 with only minor
impurities (Figure 1A), providing therefore a reliable tool for
downstream biochemical analyses. Notably, the washing condi-
tions can be varied according to the downstream applications. In
addition to these qualitative results, we performed experiments to
quantify the pull-down efficiency. For this purpose we quantified
the amount of bound GFP with varying concentrations of input
GFP from cellular extracts. After binding, the single wells were
subjected to several washing steps and bound GFP was analyzed
by fluorescent read-out using a micro plate reader. Notably, the
input amount of protein/substrate was measured in solution,
whereas the bound fraction represents one value on the 96-well
surface. We measured the fluorescence intensities of bound GFP
and plotted the amount of bound GFP as a function of total GFP
(Figure 1B). The amount of bound GFP increased linearly from 10
to 130 nM of total input and saturated between 130 and 400 nM.
Next, we quantified the amount of bound GFP by immunoblot-
ting. Therefore, we eluted the bound GFP fractions, separated
them by SDS-PAGE, visualized the bound proteins by immuno-
blot analysis (Figure 1C) and quantified the GFP signal by
measuring the mean intensity via Image J (Figure 1D). Similar to
the quantifcation by fluorescent read out using a micro plate
reader, the amount of bound GFP increases linearly from 10 to
130 nM of total input and saturates between 130 and 400 nM.
In summary, we demonstrated that the GFP-multiTrap allows
for fast and efficient one-step purification of GFP-fusion proteins
directly from crude cell lysates in a high-throughput manner. The
method works well for both qualitative and quantitative measure-
ments and the immunoprecipitated GFP-fusions can then be
further tested in biochemical assays.
In vitro Histone-tail Peptide and DNA Binding Assay
In the next assay we determined whether this approach is also
feasible to quantify binding affinities between GFP-proteins and
peptides or DNA. First, we analyzed histone-tail peptide binding
specificities of the chromobox homolog 1, Cbx1, fused with a N-
terminal GFP-tag using the GFP-multiTrap. GFP-Cbx1 was
purified from mammalian cell lysate, as described above, and the
bound protein was incubated with TAMRA-labeled histone-tail
peptides. A set of 20 different histone-tail peptides (Table 1) was
used in technical triplicates in parallel and GFP served as negative
control (GFP data is not shown). After removal of unbound
substrate the amounts of protein and histone-tail peptide were
determined by fluorescence intensity measurements using a micro
plate reader. Binding ratios were calculated by dividing the
concentration of bound histone-tail peptide by the concentration
of GFP fusion (Figure 2A). GFP-Cbx1 preferentially binds
H3K9me3 and H3K9me2 histone-tail peptides consistent with
previous studies [11,12]. As expected, the phosphorylation of
serine 10 (S10p) next to the trimethylated lysine 9 leads prevents
binding of Cbx1, which is in accordance with previous reports
[13]. In addition to fluorescent quantification via a micro plate
reader, we scanned the TAMRA signals using a Typhoon scanner
(Figure 2B). Here, we detected TAMRA signals in the wells
corresponding to di- and trimethylated H3K9. Notably, we did
not detect differences in binding towards di-and trimethylated
H3K9 using a micro plate reader. However, we could detect
a preference for tri- over dimethylated H3K9 using a fluorescence
scanner. These differences could result from different sensitivities
of both methods. Furthermore, we performed a competition assay
to demonstrate the specificity of the histone-tail peptide-binding
assay. We incubated GFP-Cbx1 with TAMRA-labeled H3K9me3
in parallel with either biotinylated H3K9me3 or H3K9ac histone-
tail peptides. As expected, the addition of biotinylated H3K9me3
histone-tail peptide significantly decreased the binding of Cbx1 to
TAMRA-labeled H3K9me3, whereas the addition of biotinylated
H3K9ac did not alter the binding ratios (Figure 2C). In previous
studies [11,12], the binding affinities of the HP1b chromo domain,
the Drosophila homolog of mammalian Cbx1, for both di- and
trimethylated H3K9 peptides have been found to be 7 and
2.5 mM, respectively. In contrast, we could not detect a significant
difference in binding ratios between di- and trimethylated H3K9
histone tail peptides using a micro plate reader (Figure 2A). One
explanation could be the use of different expression systems. While
the binding ratios for the HP1b chromo domain were determined
using bacterially expressed protein we used a fluorescent fusion
protein derived from mammalian cells. In this context a recent
study revealed that recombinant HP1a prepared from mammalian
cultured cells exhibited a stronger binding affinity for K9-
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methylated histone H3 (H3K9me) in comparison to protein
produced in Escherichia coli [21]. Biochemical analyses revealed that
HP1a was multiply phosphorylated at N-terminal serine residues
(S11–14) in human and mouse cells and that this phosphorylation
enhanced the affinity of HP1a for H3K9me, displaying the
importance of post-translational modifications for binding affinities
[21]. To determine the binding affinity of GFP-Cbx1 to
H3K9me3, we varied the input amount of histone-tail peptide.
We plotted the amount of bound histone-tail peptide as a function
of total peptide and fitted the values using GraphPad Prism and
nonlinear regression (Figure 2D). The amount of bound
H3K9me3 histone-tail peptide increases linearly and saturates at
approximately 500 nM of input peptide. In contrast to H3K9me3,
we could not detect any binding of Cbx1 to H3 histone-tail
peptides. Notably, the exact determination of binding affinities was
not possible due to differences in the technical measurement of
input versus bound fractions. Here, the input amount of protein/
substrate was measured in solution, whereas the bound fraction
represents one value on the 96-well surface.
In addition to histone-tail peptide binding assays, we performed
DNA-binding assays. We purified the methyl-binding domain
(MBD) of MeCP2, fused with a C-terminal YFP tag, from cell
extracts as described and performed competition binding analysis
by incubating immobilized MBD-YFP with fluorescently labeled
un- and fully methylated DNA (Table 1). As a result we observed
a five-fold preference of MBD for fully methylated DNA over
unmethylated DNA (Figure 2E). In addition, we measured the
amount of bound DNA to MBD-YFP by varying the input amount
of DNA. We plotted the amount of bound un- and fully
methylated DNA as a function of total un-and fully methylated
DNA and fitted the values using GraphPad Prism and nonlinear
regression (Figure 2F). Similar to the relative binding ratios, MBD
binds preferentially to fully methylated DNA. These results are in
accordance with previous studies describing that MeCP2 interacts
specifically with methylated DNA mediated by the MBD domain.
In these studies, electrophoretic mobility shift assays (EMSA) using
the isolated MBD domain expressed in E. coli were performed and
dissociation constants of 14,7 and 1000 nM were calculated for
symmetrically methylated and unmethylated DNA, respectively
[14–16].
To assess the suitability of the in vitro histone-tail peptide and
DNA binding assay for high-throughput applications, the Z-factor
was calculated. For histone-tail peptide binding assays, we
calculated the Z-factor using the relative binding ratios of
H3K9me3 to GFP-Cbx1 as positive state and of H3K9me0 to
GFP-Cbx1 as negative state. For the DNA binding assay, we
calculated the Z-factor using the relative binding ratios of fully
methylated DNA to MBD-YFP as positive state and of
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Figure 1. One-step purification of GFP and GFP-fusion proteins. Purification of GFP and GFP-Cbx1 expressed in HEK293T cells. All GFP
concentrations were quantified via plate reader. (A) Purification of GFP and GFP-Cbx1 from HEK293T cell extracts, transciently transfected with the
GFP-fusions. Input (I), flow-through (FT) and bound (B) fractions were separated by SDS-PAGE and visualized by coomassie staining. (B) Different
amounts of GFP cell lysate were added into wells of a 96-well plate immobilized with the GFP-Trap (GFP-multiTrap).Shown are means6 SD from two
independent experiments. (C) Bound GFP fractions from both independent experiments (B) were eluted, seperated by SDS-PAGE and visualized by
immunoblot analysis using an anti-GFP mouse antibody (Roche, Germany). (D) Quantification of bound GFP fractions by immunoblotting. The mean
intensities of the GFP signals were measured using Image J.
doi:10.1371/journal.pone.0036967.g001
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unmethylated DNA to MBD-YFP as negative state (Table 2). The
Z-factors of 0.766 for the histone-tail peptide binding assay and
0.756 for the DNA binding assay strongly indicate that both assays
are robust, reproducible and suitable for high-throughput applica-
tions.
In vitro Protein-protein Binding Assay
In addition to the detection of substrate specificity (e.g. histone-
tail peptide) and DNA binding, analysis of the interaction with
other cellular components and factors is essential to understand
the function of proteins.
The use of fluorescence intensity read-out systems for the
quantification of protein-protein interactions in vitro provides a new
Table 1. Sequences of DNA oligonucleotides and histone-tail peptides.
DNA oligos
DNA substrate DNA sequence DNA labeling
CG-up 59- CTCAACAACTAACTACCATCCGGACCAGAAGAGTCATCATGG -39 No
MG-up 59- CTCAACAACTAACTACCATCMGGACCAGAAGAGTCATCATGG -39 No
um550 59- CCATGATGACTCTTCTGGTCCGGATGGTAGTTAGTTGTTGAG -39 ATTO550 at 59end
um700 59- CCATGATGACTCTTCTGGTCCGGATGGTAGTTAGTTGTTGAG -39 ATTO700 at 59end
mC700 59- CCATGATGACTCTTCTGGTCMGGATGGTAGTTAGTTGTTGAG -39 ATTO700 at 59end
DNA substrates
DNA substrate CpG site Label Oligo I Oligo II
UMB-550 unmethylated 550 CG-up um550
UMB-700 unmethylated 700 CG-up um700
FMB-700 Fully methylated 700 MG-up mC700
DNA sets
Binding set Control set
UMB-550 UMB-550
FMB-700 UMB-700
Histone-tail peptides
H3 (1–20) ART K QTARKSTGGKAPRKQLK TAMRA at C-terminus
H3K4me1 ART X1 QTARKSTGGKAPRKQLK
H3K4me2 ART X2 QTARKSTGGKAPRKQLK
H3K4me3 ART X3 QTARKSTGGKAPRKQLK
H3K4ac ART Z QTARKSTGGKAPRKQLK
H3K9me1 ARTKQTAR X1 S TGGKAPRKQLK
H3K9me2 ARTKQTAR X2 S TGGKAPRKQLK
H3K9me3 ARTKQTAR X3 S TGGKAPRKQLK
H3K9me3S10p ARTKQTAR X3 Z2 TGGKAPRKQLK
H3K9ac ARTKQTAR Z S TGGKAPRKQLK
H3 (17–36) RKQLATKAAR K SAPATGGVK TAMRA at N-terminus
H3K27me1 RKQLATKAAR X1 SAPATGGVK
H3K27me2 RKQLATKAAR X2 SAPATGGVK
H3K27me3 RKQLATKAAR X3 SAPATGGVK
H3K27ac RKQLATKAAR Z SAPATGGVK
H4 (10–29) LGKGGAKRHR K VLRDNIQGI
H4K20me1 LGKGGAKRHR X1 VLRDNIQGI
H4K20me2 LGKGGAKRHR X2 VLRDNIQGI
H4K20me3 LGKGGAKRHR X3 VLRDNIQGI
H4K20ac LGKGGAKRHR Z VLRDNIQGI
X1: monomethylated Lysine; X2: dimethylated Lysine; X3: trimethylated Lysine; Z: acetylated Lysine; Z2: phosphorylated Serine.
doi:10.1371/journal.pone.0036967.t001
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Figure 2. In vitro histone-tail peptide and DNA binding assay. In vitro binding ratios of fluorescently labeled substrates over bound GFP
fusion proteins were determined. (A)–(D) In vitro histone-tail peptide binding assay with GFP-Cbx1. (A) Histone H3- and H4-tail binding specificities of
Cbx1. A final concentration of 0.15 mM TAMRA-labeled histone-tail peptide was added per well. Fluorescent signals of bound TAMRA-labeled histone-
tail peptides and GFP-fusion protein were quantified via plate reader. Shown are means 6 SD from three independent experiments (B) Fluorescent
signals of bound TAMRA-labeled histone-tail peptides visualized by fluorescent scanner. (C) Competition assay between TAMRA-labeled H3K9me3
and biotinylated histone-tail peptides with GFP-Cbx1. Shown are means 6 SD from three independent experiments. Statistical significance between
the binding ratios is indicated; **P,0.003. (D) Different amounts of TAMRA-labeled H3K9me3 and H3 histone-tail peptides were added to GFP-Cbx1.
Three or two independent experiments for H3K9me3 or H3 histone-tail peptides were performed, respectively. Shown are means 6 SD and the
amount of bound histone-tail peptide was plotted as a function of total histone-tail peptide. The curve was fitted using GraphPad Prism and
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and simple method avoiding laborious and inaccurate protein
detection using conventional immunoblotting systems.
To address the question if such interaction analysis can be
performed in a multi-well format we analyzed the interaction of
single GFP-fusions with RFP-fusion proteins expressed in mam-
malian cells. More precisely, we determined quantitative binding
ratios between nuclear located proteins involved in DNA-
replication (PCNA) [17,18], DNA-methylation (Dnmt1) [22] as
well as in DNA-repair (Xrcc1) [23]. As described, we immobilized
GFP-fusions on the GFP-multiTrap and incubated them with cell
lysate containing RFP-fusion proteins. After binding, we removed
unbound material, measured the concentrations of RFP and GFP
and calculated the molar binding ratios. Firstly, we determined the
binding ratios of the green fluorescent PCNA-binding domain of
Dnmt1 (GFP-PBD) to RFP-PCNA and used Dnmt1DPBD as
a negative control. By measuring the fluorescent signal intensities
we detected that RFP-PCNA binds to GFP-PBD in a molar ratio
of 1.4260.31 but not to Dnmt1DPBD (Figure 3A).
For a direct comparison we eluted the bound fractions,
separated them by SDS-PAGE and visualized the proteins by
immunoblotting (Figure 3B). Both, GFP-PBD and RFP-PCNA are
detected in the input and bound fractions whereas RFP is not
visible in the bound fraction of GFP-PBD (Figure 3B).
In addition, we measured the amount of bound RFP-fusion to
GFP-PBD with varying the input amount of RFP-fusion. We
plotted the amount of bound RFP-fusion as a function of total
RFP-fusion and fitted the values using GraphPad Prism and
nonlinear regression (Figure 3C). Similar to the relative binding
ratios, GFP-PBD binds to RFP-PCNA but not to RFP.
These results are in accordance with previous findings that
Dnmt1 associates with the replication machinery by directly
binding to PCNA, a homotrimeric ring which serves as loading
platform for replication factors, and that this binding depends on
the PCNA-binding domain in the very N-terminus of Dnmt1
[17,18]. In addition by determining the quantitative binding ratio
between both partner proteins our approach provides a more
detailed insight in the binding events occurring at the central
loading platform of the DNA replication.
Secondly, we determined the molar binding ratio of GFP-Ligase
III to RFP-Xrcc1. Xrcc1 binds in a molar ratio of 0.6160.14 to
Ligase III but did not bind to other proteins such as GFP-PBD,
GFP-Dnmt1DPBD or GFP. Previous studies demonstrated that
DNA Ligase III was recruited to DNA repair sites via its BRCT
domain mediated interaction with Xrcc1 [19,20].
For the protein-protein binding assays, we calculated the Z-
factor using the molar binding ratios of RFP-PCNA to GFP-PBD
as positive state and RFP to GFP-PBD as negative state (Table 2).
The Z-factor of 0.56 indicated that the protein-protein binding
assay is robust and reproducible.
In summary, we demonstrate a new quantitative and reliable
high-throughput method to analyze protein-protein interactions
using GFP- and RFP-fusion proteins.
Enzyme-linked Immunosorbent Assay (ELISA)
Next we examined endogenous protein-protein interactions
using an ELISA assay. For this purpose, we precipitated GFP-
fusion proteins in the 96 well format on the GFP-multiTrap and
cross-linked bound fractions with formaldehyde (CH2O) and/or
treated the bound fractions with methanol (MeOH). Using specific
antibodies against PCNA, we determined the binding of endog-
enous PCNA to GFP fusions of Dnmt1, Dnmt1DPBD, PCNA,
Fen1, which is a flap endonuclease and an essential DNA
replication protein [24]. We could detect endogenous PCNA
binding to Dnmt1 but not to Dnmt1DPBD similar to the results
obtained with the protein-protein interaction assay using RFP-
PCNA (Figure 4A). In addition, we detected binding of
endogenous PCNA to Fen1 but also to PCNA itself. These results
fit well to former studies showing that Fen1 or maturation factor 1
associates with PCNA in a stoichiometric complex of three Fen1
molecules per PCNA trimer [25,26]. In addition to 100 described
interacting partners, it is known that PCNA also interacts with
itself and forms a trimeric ring, which is confirmed by our ELISA
assay by giving a signal for endogenous PCNA binding to GFP-
PCNA (Figure 4A).
Next, we determined the binding of Cbx1 to endogenous
histone H3. Similar to PCNA, we precipitated GFP-Cbx1 and
GFP and detected endogenous H3 via an H3-antibody coupled to
HRP. In accordance with the experiments using TAMRA labeled
histone 3 peptides, we observed an H3 ELISA signal for binding to
Cbx1 but not to GFP. Using an H3K9me3-specific antibody, we
could not detect an ELISA signal (data not shown), due to the fact
that the tight binding of Cbx1 (Figure 2) to H3K9me3 most likely
nonlinear regression. All input and bound fractions were quantified via a plate reader. (E) DNA binding specificities of the MBD domain of MeCP2 to
un- and fully methylated DNA in direct competition. Shown are means 6 SD from three independent experiments. (F) Different amounts of Atto550-
labeled unmethylated and Atto700-labeled fully methylated DNA in direct competition were added to purified MBD-YFP. Shown are means 6 SD
from three independent experiments. The amount of bound DNA peptide was plotted as a function of total DNA. The curve was fitted using
GraphPad Prism and nonlinear regression. All input and bound fractions were quantified via a plate reader.
doi:10.1371/journal.pone.0036967.g002
Table 2. Overview of relative binding ratios and Z-factor values.
Relative binding ratios of Substrate/GFP- or YFP-fusion
Histone-tail peptide binding DNA binding Protein-protein binding
Fusion protein GFP-Cbx1 MBD-YFP GFP-PBD
Substrate H3K9me3 H3K9un Fully methylated DNA Unmethylated DNA RFP-PCNA RFP
Average ratio 0,5715 0,0772 0,0912 0,0223 1,487 0,005
Standard deviation 0,0150 0,0236 0.0037 0.0019 0,2111 0,006
Z-factor 0,766 0.756 0.560
Based on the average relative binding ratios and the standard deviations we calculated the Z-factor.
doi:10.1371/journal.pone.0036967.t002
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occludes the antibody epitope, as has been proposed for HP1
binding to H3K9me3. In this study, the histone H3 trimethyl-
lysine epitope is embedded in an aromatic cage blocking thereby
most likely the binding of any antibodies [27]. To further analyze
the bound fractions, we eluted GFP-Cbx1 and GFP, separated
them on an SDS-PAGE gel and visualized GFP and H3 by
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immunoblotting. Histone H3 was detectable in the input fractions
of both GFP and GFP-Cbx1 but as expected, only in the bound
fraction of GFP-Cbx1.
Comparative Analysis of Posttranslational Histone
Modifications
Histone posttranslational modifications play an important role
in the structural organization of chromatin and often correlate to
transcriptional activation or repression depending on their type
and location. Recently, it has been shown that nucleosomal
incorporation of histone variants can lead to alterations in
modification patterning and that such changes may complement
the properties brought by the variant itself [28].
In order to investigate the suitability of the GFP-multiTrap in
comparing such histone posttranslational modifications, we
isolated nucleosomes from HeLa cells expressing either GFP-
H2A or GFP-H2A.Z and precipitated them with the 96 well micro
plate. GFP levels were then recorded (data not shown) to ensure
equal loading of substrate per well. In addition, as a negative
control, the cytoplasmic supernatant fraction was also incubated
with the GFP-multiTrap. An ELISA approach was then used to
quantify differences in histone H3K4me2 levels between the two
different nucleosome compositions. Following cross-linking and
permeablization, bound nucleosomes were incubated with either
anti-H3, directly conjugated to HRP or anti-H3K4me2 (both
antibodies Abcam, UK). Histone H3K4me2 levels were then
normalized to the histone H3 signal. In accordance with published
data, H2A containing nucleosomes were depleted in H3K4me2
where as those containing H2A.Z showed a large enrichment for
this modification (Figure 5) [28].
Discussion
One challenge of the proteomic era is the effective integration of
proteomic, cell biological and biochemical data. Ideally, proteomic
data on tissue and cell cycle-specific expression of specific proteins
should be combined with subcellular localization and binding
dynamics of fluorescent proteins. Additionally, it is crucial to
determine cell biological and biochemical characteristics such as
interacting factors, enzymatic activity and substrate binding
specificities. The integration of all these different data has, in
part, been impeded by the simple fact that different protein tags
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endogenous Histone H3 detected by an H3 antibody to purified GFP-fusion proteins. Bound fractions were either cross-linked with 2% formaldehyde
(CH2O) and/or additionally permeabilized with MeOH. Shown are means 6 SD from two independent experiments. (C) and (D) After
immunoprecipitation input (I) and bound (B) fractions were separated by SDS-PAGE and visualized by immunoblot analysis. (C) The total protein
concentration of the input fractions were adjusted. (D) The GFP concentrations of the input fractions were adjusted.
doi:10.1371/journal.pone.0036967.g004
Versatile Toolbox for In vitro Studies
PLoS ONE | www.plosone.org 8 May 2012 | Volume 7 | Issue 5 | e36967
are used for different applications. Here, we present a new
versatile, high-throughput method to determine in vitro binding
specificities and to detect endogenous interacting factors of GFP-
fusion proteins. We use 96-well micro plates with immobilized
GFP-Trap (GFP-multiTrap) for fast and efficient purification of
GFP-fusion proteins. We demonstrate the efficiency and purity of
the GFP immunoprecipitation (Figure 1), a prerequisite to obtain
reliable biochemical data on e.g. binding specificities. Moreover,
we measured histone-tail binding, DNA and protein-protein
binding ratios underlying the versatility of our approach (Figure 2
and 3 and Table 2). The suitability of the demonstrated assays for
high-throughput biochemical and functional studies was assessed
by calculating the Z-factors (Table 2). Therefore, our assay is
suitable to examine an initial high-throughput screening for
potential binding partners. Moreover, the assay can be used for
compound screening. Additionally, our method allows for de-
tection of endogenous interaction factors based on an ELISA assay
(Figure 4 and 5).
In contrast to other high-throughput techniques like conven-
tional microarrays, it does not require time-consuming recombi-
nant protein expression and purification but allows for the direct
biochemical analyses of GFP-fusion proteins expressed in mam-
malian cells. The versatile GFP-multiTrap combined with the
widespread use of fluorescent fusion proteins now enables a fast
and direct quantitative correlation of microscopic data concerning
the subcellular localization and mobility of fluorescent fusion
proteins with their enzymatic activity, interacting factors, and
DNA binding properties combining cell biology and biochemistry
with mutual benefits.
Materials and Methods
Expression Constructs, Cell Culture and Transfection
Mammalian expression constructs encoding GFP-Dnmt1, GFP-
Dnmt1DPBD, GFP-PBD, GFP-PCNA, RFP-PCNA, GFP-Ligase
III, mRFP, GFP, MBD-YFP, GFP-Fen1 and RFP-Xrcc1 were
described previously [7,20,29–37]. Note that all constructs encode
fusion proteins of GFP, RFP or yellow fluorescent protein (YFP).
The Cbx1 expression construct was derived by PCR from mouse
cDNA, cloned into pEGFP-C1 (Clontech, USA) and verified by
DNA sequencing. Throughout this study enhanced GFP (eGFP)
constructs were used and for simplicity referred to as GFP-fusions.
HEK293T cells [30] and HeLa Kyoto [29] were cultured in
DMEM supplemented with either 50 mg/ml gentamicin
(HEK293T) or 1% penicillin/streptomycin (HeLa Kyoto) and
10% fetal calf serum. For expression of GFP/RFP/YFP fusion
proteins, HEK293T cells were transfected with the corresponding
expression constructs using polyethylenimine (Sigma, USA). 2.
HeLa Kyoto cells were transfected using FuGene HD (Roche,
Germany) according to the manufacturer’s instructions. The
plasmid coding for GFP-H2A (H2A type 1, NP_003501.1) was
kindly provided by Emily Bernstein (Mount Sinai Hospital) and
the plasmid coding for GFP-Z-1 was a gift from Sachihiro
Matsunaga (University of Tokyo). Stable cell lines were selected
with 600 mg/ml G418 (PAA, Austria) and individual cell clones
sorted by using a FACSAria machine (Becton Dickinson,
Germany).
Histone-tail Peptides and DNA Substrate Preparation
Fluorescently labeled DNA substrates were prepared by mixing
two HPLC-purified DNA oligonucleotides (IBA GmbH, Germany
Table 1) in equimolar amounts, denaturation for 30 sec at 92uC
and slow cool-down to 25uC allowing hybridization. Histone-tail
peptides were purchased as TAMRA conjugates and/or biotiny-
lated (PSL, Germany) and are listed in Table 1.
Preparation of Protein Extracts
HEK293T cells were cultured and transfected as described [38].
For extract preparation 1 mg/ml DNaseI, 1 mM PMSF and
Protease Inhibitor cocktail (Roche, Germany) were included in the
lysis buffer (20 mM Tris-HCl pH 7.5, 150 mM NaCl, 2 mM
MgCl2, 0.5% NP40) or nuclear extract buffer (10 mM HEPES
pH 7.9, 10 mM KCl, 1.5 mMMgCl2, 0.34 M Sucrose, 10%Glyc-
erol, 1 mM b-mercapto-ethanol). Cells were lysed for 30 minutes
on ice followed by a centrifugation step (15`/12000 rpm/4uC).
Extracts from transfected 10 cm plates were diluted to 500 mL
with immunoprecipitation buffer (IP buffer; 20 mM Tris-HCl
pH 7.5, 150 mM NaCl, 0.5 mM EDTA) or dilution buffer
(20 mM HEPES pH 7.9, 150 mM KCl). An aliquot of 10 mL
(2%) were added to SDS-containing sample buffer (referred to as
Input (I)).
Purification and Elution of GFP/YFP/RFP- Fusions
For purification, 100 mL or 50 mL precleared cellular lysate
for full-area plates or half-area plates, respectively, was added
per well and incubated for 2 hours at 4uC on a GFP-multiTrap
plate by continuous shaking. After removing the supernatant,
wells were washed twice with 100 mL of washing buffer (WB;
20 mM Tris-HCl pH 7.5, 100–300 mM NaCl, 0.5 mM EDTA)
and 100 mL of IP or dilution buffer was added for measure-
ment. The amounts of bound protein were determined by
fluorescence intensity measurements with a Tecan Infinite
M1000 plate reader (Tecan, Austria). Wavelengths for excitation
and emission of GFP are 490610 nm and 511610 nm, for
RFP are 58665 nm and 608610 nm and for YFP 52565 nm
and 53865 nm, respectively. The concentration of proteins was
calculated using calibration curves that were determined by
measuring the fluorescence signal of known concentrations of
purified GFP, RFP and YFP. Notably, factors interfering with
H2A H2A.Z H2A H2A.Z
Supernatant Nucleosomes
0
0.2
0.4
0.6
0.8
1.0
1.2
D
et
ec
tio
n 
of
 e
nd
og
en
ou
s 
H
3K
4m
e2
GFP-fusion proteins
Figure 5. Comparative analysis of posttranslational histone
modifications. Cytoplasmic supernatant (SN) or mononucleosome
(MN) fractions prepared from HeLa cells expressing GFP-H2A or GFP-
H2A.Z were precipitated and the levels of H3 and H3K4me2 were
detected by ELISA (Absorbance at 450 nm). Shown are the H3K4me2
levels normalized to H3 and means 6 SD from two independent
experiments.
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fluorescence intensity measurements such as absorption of
excitation light by cell lysates, auto fluorescence of the samples
and/or scattering of the excitation/emission light by cell debris
are negligible (Figure S1). Bound proteins were eluted with
300 mM Glycin pH 2.5 and subsequently buffered with 1 M
Tris pH 7.5. Elution fractions were added to SDS-containing
sample buffer (referred to as Bound (B)). Bound proteins were
visualized by immunoblotting using the anti-GFP mouse mono-
clonal antibody (Roche, Germany).
In vitro Histone-tail Peptide Binding Assay
The in vitro histone-tail binding assay was performed as
described previously [10]. After one-step purification of GFP
fusion proteins the wells were blocked with 100 mL 3% milk
solved in TBS-T (0.075% Tween) for 30 minutes at 4uC on
a plate vortex, shaking gently. After blocking, the wells were
equilibrated in 50 mL IP buffer supplemented with 0.05%
Tween. TAMRA-labeled histone-tail peptides were added either
to a final concentration of 0.15 mM or of the indicated
concentrations and the binding reaction was performed at RT
for 20 min on a plate vortex, shaking gently. After removal of
unbound substrate the amounts of protein and histone-tail
peptide were determined by fluorescence intensity measurements.
The concentrations of bound TAMRA-labeled histone-tail
peptides were calculated using calibration curves that were
determined by measuring a serial dilution of TAMRA-labeled
peptides with known concentrations.
Binding ratios were calculated dividing the concentration of
bound histone-tail peptide by the concentration of GFP fusion.
Wavelengths for excitation and emission of TAMRA were
56065 nm and 58665 nm, respectively.
In vitro DNA Binding Assay
In vitro DNA binding assay was performed as described
previously [9,10] with the following modifications. GFP/YFP
fusions were purified from HEK293T extracts using the 96-well
GFP-binder plates and incubated with two differentially labeled
DNA substrates at a final concentration of either 100 nM or of the
indicated concentration for 60 min at RT in IP buffer supple-
mented with 2 mM DTT and 100 ng/mL BSA. After removal of
unbound substrate the amounts of protein and DNA were
determined by fluorescence intensity measurements. The concen-
tration of bound ATTO-labeled DNA substrates was calculated
using calibration curves that were determined by measuring a serial
dilution of DNA-coupled fluorophores with known concentrations.
Binding ratios were calculated dividing the concentration of bound
DNA substrate by the concentration of GFP/YFP fusion,
corrected by values from a control experiment using DNA
substrates of the same sequence but with different fluorescent
label, and normalized by the total amount of bound DNA.
Wavelengths for excitation and emission of ATTO550 were
54565 nm and 57565 nm and for ATTO700 700610 nm and
720610, respectively.
Protein-Protein Interaction
GFP fusions were purified from HEK293T extracts using the
96-well GFP multiTrap plates, blocked with 3% milk and
incubated with cellular extracts comprising the RFP fusions with
the indicated concentrations for 30 min at RT. After removal of
unbound RFP fusion (washing buffer) the amounts of proteins
were determined by fluorescence intensity measurements. Binding
ratios were calculated dividing the concentration of bound RFP
fusion by the concentration of GFP fusion. Wavelengths for
excitation and emission of RFP were 58665 nm and 608610 nm,
respectively. Bound proteins were eluted and separated by SDS-
PAGE and visualized by immunoblotting using the anti-GFP rat
monoclonal antibody; 3H9, and the anti-red rat monoclonal
antibody, 5F8 (both ChromoTek, Germany).
Enzyme-linked Immunosorbent Assay (ELISA)
GFP fusions were purified (from HEK293T extracts) using the
96-well GFP-multiTrap plates and were washed twice with
dilution buffer (for nucleosome experiments salt concentration
was adjusted to 300 mM). After washing bound fractions were
either cross-linked with 2% formaldehyde and/or additionally
permeabilized with 100% MeOH. After blocking with 3% milk
solved in TBS-T (0.075% Tween) the wells were incubated with
primary antibody (monoclonal rat anti-H3-HRP (Abcam, UK),
polyclonal rabbit anti-H3K4me2 (Abcam, UK) or monoclonal rat
anti-PCNA, 16D10 (ChromoTek, Germany) overnight at 4uC on
a plate vortex, shaking gently. The wells were washed three times
with 200 mL TBS-T and horseradish peroxidase-conjugated
secondary antibody (Sigma, USA) was incubated for 1 h at RT
for the detection of PCNA or H3K4me2. The wells were washed
again as described above. For PCNA experiments detection was
carried out by incubating each well with 100 mL TMB (3,39,5,59-
tetramethylbenzidine) for 10 minutes at RT. The reactions were
stopped with the addition of 100 mL 1 M H2SO4. For nucleosome
experiments, detection was carried out using OPD (Sigma, USA)
according to the manufacturers instructions. Bound histone H3,
PCNA or H3K4me2 levels were quantified by determination of
the absorbance at 450 nm using a Tecan Infinite M1000 plate
reader (Tecan, Austria).
Preparation of Mononucleosomes
261072106107HeLa cells, expressing eitherGFP-H2A orGFP-
H2A.Z, were incubated in PBS, 0.3% Triton X-100 and Protease
InhibitorCocktail (Roche,Germany) for 10 min at 4uC.Nuclei were
pelleted and supernatant (SN) transferred and retained. The pellet
was washed once in PBS, resuspended in EX100 buffer (10 mM
Hepes pH 7.6, 100 mM NaCl, 1.5 mM MgCl2, 0.5 mM EGTA,
10% (v/v) glycerol, 10 mM b-glycerol phosphate 1 mM DTT,
Protease Inhibitor Cocktail (Roche, Germany)) and CaCl2 concen-
tration adjusted to 2 mM. Resuspended nuclei were digested with
1.5 U MNase (Sigma, USA) for 20 min at 26uC. The reaction was
stopped by addition of EGTA to a final concentration of 10 mM
followed by centrifugation for 10 min at 1000 rcf, 4uC. Mono-
nucleosome containing supernatant (MN) was retained.
Calculation of the Z-factors
To assess the suitability of the assay for high-throughput
biochemical and functional studies, the Z-factor was calculated
using the equation Z~1{
3| spzsnð Þ
Dmp{mn D
[39]. In this equation, s is
the standard deviation of the positive (p) and the negative (n)
control; m is the mean value for the molar binding ratio (for
positive (mp) and negative (mn) controls). The values of three
independent experiments were used to calculate the Z-factor and
all values are listed in Table 2.
Supporting Information
Figure S1 Factors interfering the measured fluores-
cence intensities. (A) The concentrations of GFP and RFP
expressed in HEK293T cells were measured in serial dilutions of
crude cell extracts. Shown are means 6 SD from two independent
experiments. Fluorescence intensities were measured via a plate
reader and the GFP and RFP concentrations were determined as
described in the Material and Methods part. (B) Background GFP
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and RFP signals in cell lysates of untransfected HEK293T cells.
The fluorescence intensities (FI) were measured via a plate reader
and the concentrations were determined as described in the
Material and Methods part.
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